Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma and Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03474640
What this trial is testing

Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies

Who this might be right for
Advanced Malignancies
TopAlliance Biosciences 184
Early research (Phase 1)Active Not RecruitingNCT04658147
What this trial is testing

Feasibility and Efficacy of Perioperative Nivolumab With or Without Relatlimab for Patients With Potentially Resectable Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 31
Not applicableLooking for participantsNCT04190849
What this trial is testing

European Paediatric Non-Alcoholic Fatty Liver Disease Registry (EU-PNAFLD)

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon-alcoholic Fatty LiverNon-alcoholic Steatohepatitis
Cambridge University Hospitals NHS Foundation Trust 2,000
Not applicableLooking for participantsNCT05199259
What this trial is testing

Multi-analyte Blood Test Clinical Trial

Who this might be right for
Liver CirrhosisLiver CancerHCC+1 more
Helio Genomics 1,200
Not applicableStudy completedNCT02582918
What this trial is testing

Texas Hepatocellular Carcinoma Consortium (THCCC) Project 5

Who this might be right for
Carcinoma, HepatocellularLiver Neoplasms
University of Texas Southwestern Medical Center 2,871
Testing effectiveness (Phase 2)Active Not RecruitingNCT02519348
What this trial is testing

Durvalumab or Tremelimumab Monotherapy, or Durvalumab in Combination With Tremelimumab or Bevacizumab in Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
MedImmune LLC 433
Testing effectiveness (Phase 2)Looking for participantsNCT07479485
What this trial is testing

MRG006A Combination Therapy for Advanced Hepatocellular Carcinoma (Phase I/II)

Who this might be right for
Hepatocellular Carcinoma
Lepu Biopharma Co., Ltd. 160
Not applicableStudy completedNCT02983968
What this trial is testing

Use of the French Healthcare Insurance Database

Who this might be right for
Cirrhosis
Centre Hospitalier Universitaire, Amiens 75,868
Not applicableUnknownNCT05627297
What this trial is testing

Applying Artificial Intelligence to Optimize Early-stage Hepatocellular Carcinoma Treatment Based on Multi-modal Image

Who this might be right for
Hepatocellular Carcinoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 200
Not applicableStudy completedNCT06881433
What this trial is testing

Immune Checkpoint Inhibitors and Anti-vascular Endothelial Growth Factor Antibody/Tyrosine Kinase Inhibitors With or Without HAIC for Unresectable HCC With Portal Vein Tumor Thrombosis

Who this might be right for
Hepatocellular Carcinoma (HCC)
Zhongda Hospital 1,649
Testing effectiveness (Phase 2)UnknownNCT04483284
What this trial is testing

Study of TACE Combined With Camrelizumab in the Treatment of HCC Patients

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 28
Large-scale testing (Phase 3)UnknownNCT05408221
What this trial is testing

The Efficacy and Safety of Rulonilimab in Combination With Lenvatinib in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Shandong New Time Pharmaceutical Co., LTD 576
Not applicableActive Not RecruitingNCT05657249
What this trial is testing

Alternative Surveillance Program for Patients With High Risk Group of HCC

Who this might be right for
Hepatocellular Carcinoma
Seoul National University Hospital 199
Testing effectiveness (Phase 2)Study completedNCT03199274
What this trial is testing

Perflutren Protein-Type A Microspheres and Contrast-Enhanced Ultrasound in Improving Response to Radioembolization Therapy in Patients With Liver Cancer

Who this might be right for
Hepatocellular Carcinoma
Thomas Jefferson University 104
Testing effectiveness (Phase 2)Study completedNCT03682276
What this trial is testing

Safety and Bioactivity of Ipilimumab and Nivolumab Combination Prior to Liver Resection in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Imperial College London 33
Large-scale testing (Phase 3)UnknownNCT03974074
What this trial is testing

Albumin for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaHypoproteinemia
Guangxi Medical University 200
Not applicableStudy completedNCT04642547
What this trial is testing

Lenvatinib Combined With Gefitinib in the Treatment of Lenvatinib-resistant Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaMolecular Targeted Therapy
RenJi Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07192848
What this trial is testing

Adebrelimab + Apatinib in Advanced HCC Post-Systemic Therapy

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Song Peng 47
Not applicableEnded earlyNCT01167374
What this trial is testing

Carbon Ion Radiotherapy for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
University Hospital Heidelberg 21
Testing effectiveness (Phase 2)Looking for participantsNCT06349317
What this trial is testing

Neoadjuvant IMRT Combined With Camrelizumab and Apatinib for Resectable HCC With PVTT

Who this might be right for
Hepatocellular Carcinoma
Yongyi Zeng 33
Next Page